|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 1.730 SEK | -2.81% |
|
0.00% | -8.95% |
| 09-02 | Enzymatica CEO buys additional shares | FW |
| 09-01 | Enzymatica CEO buys 33 384 shares | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 43.02M | - | - | - | - | - |
| 1,019B | |||||
| 610B | - | ||||
| 470B | |||||
| 344B | |||||
| 336B |
- Stock Market
- Stocks
- ENZY Stock
- Charts Enzymatica AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
